Orexigen Therapeutics (OREX)
Orexigen Therapeutics Balance Sheet
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Assets | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Cash & Short Term Investments | 138.58M | 147.59M | 63.84M | 69.70M | 76.58M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Receivables | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Inventory | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Prepaid Expenses | 1.287M | 1.126M | 0.897M | 1.309M | 1.056M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Current Assets | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Current Assets | 139.87M | 148.72M | 64.73M | 71.01M | 77.64M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Gross Property, Plant & Equipment | 1.993M | 2.136M | 2.276M | 2.276M | 2.276M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Accumulated Depreciation | 1.674M | 1.697M | 1.73M | 1.622M | 1.502M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Property, Plant & Equipment | 0.319M | 0.439M | 0.546M | 0.654M | 0.774M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Long Term Investments | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Goodwill & Intangibles | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Long Term Assets | 0.542M | 0.542M | 0.614M | 0.623M | 0.988M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Long Term Assets | 0.861M | 0.981M | 1.16M | 1.277M | 1.762M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Assets | 140.73M | 149.70M | 65.89M | 72.28M | 79.40M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Liabilities | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Current Portion of Long Term Debt | 0.205M | 1.067M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||
| Accounts Payable | 5.002M | 4.277M | 3.524M | 5.60M | 5.047M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Accrued Expenses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Deferred Revenues | 3.429M | 3.429M | 3.429M | 3.429M | 3.429M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Current Liabilities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Current Liabilities | 8.431M | 7.706M | 6.953M | 9.234M | 9.543M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Long Term Debt | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Shareholder's Equity | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Deferred Income Tax | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Long Term Liabilities | 0.215M | 0.288M | 0.323M | 0.383M | 0.428M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Long Term Liabilities | 41.36M | 42.29M | 43.18M | 44.10M | 45.00M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Liabilities | 49.79M | 49.99M | 50.13M | 53.33M | 54.54M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Common Shares Outstanding | 67.78M | 61.29M | 48.08M | 48.08M | 48.08M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Preferred Stock | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Common Stock, Net | 0.068M | 0.061M | 0.048M | 0.048M | 0.048M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Additional Paid-in Capital | 448.00M | 446.36M | 358.11M | 356.72M | 355.06M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Retained Earnings | -357.12M | -346.71M | -342.40M | -337.82M | -330.26M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Treasury Stock | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Shareholder's Equity | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Shareholder's Equity | 90.94M | 99.71M | 15.76M | 18.95M | 24.86M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Liabilities & Shareholder's Equity | 140.73M | 149.70M | 65.89M | 72.28M | 79.40M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |